Article content
The Ottawa Hospital’s Biotherapeutics Manufacturing Centre is producing three experimental COVID-19 vaccines for human trials.
The first of the three, a DNA-based vaccine called Covigenix VAX-001, is already headed to Halifax for a Phase 1 clinical trial, likely to begin within a week, pending permission from Health Canada.
We apologize, but this video has failed to load.
Try refreshing your browser, or
'All ready to go': Ottawa manufacturing centre producing three COVID vaccines for human trials Back to video
“They’ve just finished. It’s all ready to go. They are literally printing the labels,” said John Lewis, CEO of Entos Pharmaceuticals in Alberta, which developed the vaccine.